Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Mechanisms Induced by Enteral Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA) Supplementation in Preterm Infants

NCT05380401 is registered in ClinicalTrials.gov with The University of Texas Health Science Center at San Antonio as lead sponsor.

NCT NCT05380401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05380401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Mechanisms Induced by Enteral Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA) Supplementation in Preterm Infants
Lead sponsor
The University of Texas Health Science Center at San Antonio
Phase
Not applicable
Overall status
Recruiting
Start date
March 9, 2023
Completion date
April 30, 2028
Enrollment
328 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

premature